GlassScriptPhysician profile
Candi Estes
NPI 1396163879
$720.33
in general payments reported to CMS, 2019-2025
12 companies · $378 in 2025
The $378 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $50.08 · 2023: $20.42 · 2024: $272 · 2025: $378.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $670.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $670.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $229.83 | 2022-2025 | Wegovy, Rybelsus, Ozempic |
| Radius Health, INC. | $97.12 | 2024-2025 | Tymlos |
| Glaxosmithkline, LLC. | $85.07 | 2024-2025 | Shingrix, Arexvy, Bexsero |
| Abbvie INC. | $68.90 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $68.50 | 2024-2025 | Capvaxive, Vaxneuvance, Gardasil 9 |
| Lilly USA, LLC | $60.53 | 2022-2024 | Mounjaro, Zepbound, Jardiance |
| Novartis Pharmaceuticals Corporation | $20.42 | 2023 | |
| Corcept Therapeutics | $19.99 | 2025 | Korlym |
| Pfizer INC. | $19.96 | 2025 | |
| Sanofi Pasteur INC. | $18.77 | 2022 | |
| Amgen INC. | $17.64 | 2025 | Krystexxa |
| Janssen Pharmaceuticals, INC | $13.60 | 2025 | Spravato |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Candi Estes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.